Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation of dihydroxy ketene oleanolic acid methyl ester and antiviral application of dihydroxy ketene oleanolic acid methyl ester

A technology of methyl dihydroxyketene oleanate and carbonyl oleanane, which is applied in the field of medicine, can solve the problems that have not been effectively developed, and achieve the effects of clear industrialization prospects, rich sources of raw materials, and wide distribution

Inactive Publication Date: 2020-11-06
DALI UNIV
View PDF44 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above pharmacological studies or clinical application studies all use this natural product or its derivatives as liver-protecting drugs, and its structurally modified derivatives have been reported in relatively few literatures in antiviral treatment. Oleanolic acid derivatives treat DNA-like virus infections , especially its new application for anti-hepatitis B virus (comprising inhibition of hepatitis B HBsAg and / or HBeAg antigen, inhibition of HBV-DNA replication) has not been effectively developed, so from oleanolic acid derivatives to find the field of anti-hepatitis B virus Active compounds, that is to say, such structural modification to have anti-DNA virus activity is a new field

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation of dihydroxy ketene oleanolic acid methyl ester and antiviral application of dihydroxy ketene oleanolic acid methyl ester
  • Preparation of dihydroxy ketene oleanolic acid methyl ester and antiviral application of dihydroxy ketene oleanolic acid methyl ester
  • Preparation of dihydroxy ketene oleanolic acid methyl ester and antiviral application of dihydroxy ketene oleanolic acid methyl ester

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Example 1 : the preparation of formula (1) compound

[0032] 1.1 Instruments and reagents

[0033] The ultraviolet spectrum was measured with a Shimadzu UV-240 ultraviolet spectrophotometer; the nuclear magnetic resonance spectrum was measured by an INOVA type superconducting nuclear magnetic resonance spectrometer (VARIAN INOVA-400MHz) (tetramethylsilyl ether TMS was the internal standard); electrospray mass spectrometry ESI- MS was determined by Bruker Esquire 3000+ mass spectrometer; silica gel for column chromatography (100-200, 200-300 and 300-400 mesh) and silica gel GF254 for thin-layer chromatography (10-40 mesh) were all produced by Qingdao Ocean Chemical Factory The reagents used are all analytically pure, wherein petroleum ether boiling range is 60~90 ℃; High performance liquid phase detection (HPLC) uses Agilent 1100 instrument; Preparative thin layer chromatography (PTLC) uses the aluminum foil silica gel plate of Merck Company; The dextran gel Sephadex L...

Embodiment 2

[0048] Example 2 : the inhibitory effect of formula (1) compound on hepatitis B surface antigen (HBsAg)

[0049] 2.1 Cell culture:

[0050] HepG2.2.15 cells were cultured in DMEM medium containing 10% inactivated fetal bovine serum, 100 U / ml penicillin and 100 U / ml streptomycin, and 100 μg / ml G418 at 37°C, 5% CO 2 , cultured in an incubator with 100% relative humidity.

[0051] 2.2 Determination of the inhibitory effect of the test sample on the HBsAg secreted by HepG2.2.15 cells:

[0052] Take the HepG2.2.15 cells in the logarithmic growth phase, and dilute the cells to 1×10 with medium 5 / ml, seeded in 96-well cell culture plate, 100ml per well, at 37°C, 5% CO 2 After culturing in an incubator with 100% relative humidity for 24 hours, add the test sample diluted with the medium, set up three replicate holes for each concentration, 200 microliters per hole, place at 37°C, 5% CO 2 , cultivated in an incubator with 100% relative humidity, change the culture medium contain...

Embodiment 3

[0059] Example 3 : the inhibitory effect of formula (1) compound on hepatitis B e antigen (HBeAg)

[0060] 3.1 Cell culture: the method is the same as in Example 2.

[0061] 3.2 Determination of the inhibitory effect of the test sample on the HBeAg secreted by HepG2.2.15 cells:

[0062] Take the HepG2.2.15 cells in the logarithmic growth phase, and dilute the cells to 1×10 with medium 5 / ml, seeded in 96-well cell culture plate, 100ml per well, at 37°C, 5% CO 2 After culturing in an incubator with 100% relative humidity for 24 hours, add the test sample diluted with the medium, set up three replicate holes for each concentration, 200 microliters per hole, place at 37°C, 5% CO 2 , cultivated in an incubator with 100% relative humidity, change the culture medium containing the same concentration sample every 4 days, mix the same volume of the culture medium with the same concentration of the same sample and the same concentration, and use it as the sample to be tested. On t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Melting pointaaaaaaaaaa
Login to View More

Abstract

The invention relates to preparation of dihydroxy ketene oleanolic acid methyl ester and antiviral application of the dihydroxy ketene oleanolic acid methyl ester. Specifically, the invention relatesto application of a compound shown as a formula (1), namely 2alpha,3beta-dihydroxy-11-carbonyl oleanane-12-ene-28-carboxylic acid methyl ester, in preparation of a medicine for treating hepatitis B virus infection diseases. The compound shown in the formula (1) has remarkable activity of inhibiting HBsAg and HBeAg secreted by HepG2.2.15 cells; on the eighth day, the HBsAg and HBeAg secretion inhibition intensities of the compound are 82.4% and 65.5% respectively at a concentration of 100 mg / ml, and at the concentration, the HBV-DNA inhibition rate of the compound is 84.9%, is 2.78 times of that of alpha-interferon and is higher than that of positive control lamivudine. The above results show that the 2alpha,3beta-dihydroxy-11-carbonyl oleanane-12-ene-28-carboxylic acid methyl ester or thepharmaceutically acceptable salt thereof can be expected to be used for preparing non-nucleoside drugs for treating hepatitis B virus infection diseases.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to the preparation of methyl dihydroxyketene oleanate and its antiviral application. The compound is a pentacyclic triterpene acid with the structure of 2α, 3β-dihydroxy-11-carbonyloleanane-12-ene-28-carboxylic acid methyl ester, which has the definite inhibitory effect on the secretion of HBsAg and HBeAg from HepG2.2.15 cells activity, and can significantly inhibit the replication of HBV-DNA in HepG2.2.15 cells, and can be expected to be used for the preparation of non-nucleoside innovative drugs for clearing HBsAg and HBeAg, inhibiting HBV-DNA replication, and treating hepatitis B virus infection diseases . Background technique [0002] Hepatitis B is an infectious disease caused by hepatitis B virus (HBV, hepatitis B virus), so it is also called viral hepatitis B. HBV is a member of the hepadnaviridae family of hepadnaviridae. It is a partial circular DNA virus with a shape of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/56A61P1/16A61P31/20
CPCA61K31/56A61P1/16A61P31/20
Inventor 巫秀美莽朝永王静曾菁张旭强彭芳杨志斌赵昱
Owner DALI UNIV